IDV vehicle
75N91024D00005
PRECLINICAL EFFICACY & INTERMEDIATE ENDPOINT BIOMARKERS IDIQ CONTRACT IN SUPPORT OF THE PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NIH NCI |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | ORDER DEPENDENT (IDV ALLOWS PRICING ARRANGEMENT TO BE DETERMINED SEPARATELY FOR EACH ORDER) |
| Obligations | $0 |
| Current contract value | Not reported |
| Potential contract value / ceiling | $150.0M |
| Start date | Jan 25, 2024 |
| Current end date | Not available |
| Potential end date | Not available |
| Latest award activity | Jul 9, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 4 of 4 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jul 9, 2026 | P00005 | $0 | EO 14398; PRECLINICAL EFFICACY & INTERMEDIATE ENDPOINT BIOMARKERS IDIQ CONTRACT IN SUPPORT OF THE PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM |
| May 14, 2026 | P00004 | $0 | PRECLINICAL EFFICACY & INTERMEDIATE ENDPOINT BIOMARKERS IDIQ CONTRACT IN SUPPORT OF THE PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM |
| Jan 10, 2025 | P00003 | $0 | PRECLINICAL EFFICACY & INTERMEDIATE ENDPOINT BIOMARKERS IDIQ CONTRACT IN SUPPORT OF THE PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM |
| Oct 24, 2024 | P00002 | $0 | PRECLINICAL EFFICACY & INTERMEDIATE ENDPOINT BIOMARKERS IDIQ CONTRACT IN SUPPORT OF THE PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM |
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| TAYLOR, RICHARD | Contact | rich.taylor@nih.gov +1 717 339 9735 | Source | Sep 16, 2024 |
| TAYLOR, RICHARD | Contact | rich.taylor@nih.gov +1 717 339 9735 | Source | Feb 23, 2023 |
| TAYLOR, RICHARD | Contact | rich.taylor@nih.gov +1 717 339 9735 | Source | Jan 31, 2023 |
| TAYLOR, RICHARD | Contact | rich.taylor@nih.gov +1 717 339 9735 | Source | Jan 6, 2023 |
| MILLS, CARRIE L | Contact | carrie.mills@nih.gov 301 624 1274 | Source | Dec 29, 2022 |
| MILLS, CARRIE L | Contact | carrie.mills@nih.gov 301 624 1274 | Source | Dec 19, 2022 |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.